Determinants of increased opioid-related mortality in the United States and Canada, 1990-2013: a systematic review.
Nicholas B King, Veronique Fraser, Constantina Boikos, Robin Richardson, Sam Harper
Index: Am. J. Public Health 104(8) , e32-42, (2014)
Full Text: HTML
Abstract
We review evidence of determinants contributing to increased opioid-related mortality in the United States and Canada between 1990 and 2013. We identified 17 determinants of opioid-related mortality and mortality increases that we classified into 3 categories: prescriber behavior, user behavior and characteristics, and environmental and systemic determinants. These determinants operate independently but interact in complex ways that vary according to geography and population, making generalization from single studies inadvisable. Researchers in this area face significant methodological difficulties; most of the studies in our review were ecological or observational and lacked control groups or adjustment for confounding factors; thus, causal inferences are difficult. Preventing additional opioid-related mortality will likely require interventions that address multiple determinants and are tailored to specific locations and populations.
Related Compounds
Related Articles:
Differentiation between human ClC-2 and CFTR Cl- channels with pharmacological agents.
2014-09-01
[Am. J. Physiol. Cell Physiol. 307(5) , C479-92, (2014)]
2014-12-01
[Anesthesiology 121(6) , 1281-91, (2014)]
Disaccharides in urine samples as markers of intravenous abuse of methadone and buprenorphine.
2013-01-01
[J. Anal. Toxicol. 37(9) , 652-8, (2013)]
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
2014-12-01
[Presse Med. 43(12 Pt 1) , 1314-6, (2014)]
Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
2014-12-15
[J. Acquir. Immune Defic. Syndr. 67(5) , e142, (2014)]